carbapenems has been researched along with temocillin in 7 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (temocillin) | Trials (temocillin) | Recent Studies (post-2010) (temocillin) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 216 | 17 | 78 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Cattoir, V; Daurel, C | 1 |
| Apfalter, P; Hartl, R; Kerschner, H; Widhalm, S | 1 |
| Arlet, G; Bidet, P; Bingen, E; Decré, D; Lafeuille, E; Mahjoub-Messai, F | 1 |
| Lavigne, JP; Meiller, E; Merens, A; Nicolas-Chanoine, MH; Pantel, A; Robert, J | 1 |
| Berthault, C; Bonnin, RA; Dortet, L; Iorga, BI; Marchini, L; Naas, T; Oueslati, S; Retailleau, P | 1 |
| Davido, B; Delory, T; Gaube, G; Gravier, S; Lafaurie, M; Le Pluart, D; Lepeule, R; Lesprit, P; Piet, E; Simeon, S | 1 |
| Ghasemi, H; Sabouri, M; Seyedifar, M; Soodi, O | 1 |
1 review(s) available for carbapenems and temocillin
| Article | Year |
|---|---|
[Update on antimicrobial chemotherapy].
Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Daptomycin; Doripenem; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; France; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Penicillins; Pyrimidines; Teicoplanin; Tigecycline | 2010 |
6 other study(ies) available for carbapenems and temocillin
| Article | Year |
|---|---|
Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Meropenem; Microbial Sensitivity Tests; Penicillins; Thienamycins | 2013 |
OXA-48 carbapenemase-producing Klebsiella pneumoniae isolated from Libyan patients.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Gene Expression; Gene Transfer, Horizontal; Humans; Klebsiella Infections; Klebsiella pneumoniae; Libya; Microbial Sensitivity Tests; Penicillins; Plasmids | 2013 |
Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory.
Topics: Algorithms; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Clavulanic Acids; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Tazobactam; Thienamycins; Ticarcillin | 2017 |
Role of Arginine 214 in the Substrate Specificity of OXA-48.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Arginine; Bacterial Proteins; beta-Lactamases; Carbapenems; Crystallography, X-Ray; Drug Resistance, Bacterial; Enterobacteriaceae; Imipenem; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Mutation; Penicillins; Substrate Specificity | 2020 |
Temocillin versus carbapenems for urinary tract infection due to ESBL-producing Enterobacteriaceae: a multicenter matched case-control study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Retrospective Studies; Treatment Outcome; Urinary Tract Infections | 2021 |
Budget impact analysis of temocillin insurance coverage for urinary tract infections caused by ESBL-producing pathogens in Iran.
Topics: Anti-Bacterial Agents; Carbapenems; Female; Humans; Hydrolases; Insurance Coverage; Iran; Urinary Tract Infections | 2023 |